Trial Profile
Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tisagenlecleucel (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors Beijing Sanwater Biological Technology
- 05 Jul 2016 New trial record